The epithelial-mesenchymal transition (EMT) has a crucial role in normal and disease processes including tumor progression. In this study, we first classified epithelial-like and mesenchymal-like oral squamous cell carcinoma (OSCC) cell lines based on expression profiles of typical EMT-related genes using a panel of 18 OSCC cell lines. Then, we performed methylation-based and expression-based analyses of components of the Wnt signaling pathway, and identified WNT7A and WNT10A as genes silenced by mesenchymal-specific DNA hypermethylation in OSCCs. A significant association was revealed between some clinicopathological findings and the DNA methylation status of WNT7A (normal vs tumor, P ¼ 0.007; T1-2 vs T3-4, P ¼ 0.040; I-III vs IV, P ¼ 0.016) and WNT10A (N0-N1 vs N2-N3, P ¼ 0.046) in the advanced stages of OSCC. Moreover, we found that E-cadherin expression in cancer cells may be positively regulated by WNT7A, whose expression is negatively regulated by mesenchymal-specific DNA hypermethylation or ZEB1 in mesenchymal-like OSCC cells. Our findings indicate that epithelial-specific gene silencing through mesenchymal-specific DNA hypermethylation may stabilize the phenotypic plasticity of cancer cells during EMT/MET.
Introduction
The epithelial-mesenchymal transition (EMT) is one of the central events that enable an epithelial cell to become a mesenchymal cell, and has crucial roles in embryonic development, organ and tissue regeneration, and of malignant transformation in cancer cells, including invasion and metastasis (Kalluri and Weinberg, 2009; Thiery et al., 2009) . Several molecular mechanisms have already been shown to underlie EMT/mesenchymal-toepithelial transition (MET) in development and carcinogenesis, such as the TGF-b/Smad and Wnt pathways (Moustakas and Heldin, 2007; Yang and Weinberg, 2008) . The Wnt genes encode a large family of secreted growth factors, which regulate cell polarity, cell migration and cell fate specification through canonical and noncanonical signaling pathways by binding to cellsurface frizzled receptors (McNeill and Woodgett, 2010) . Some components of the Wnt signaling pathway components have recently been reported to be associated with the promotion of EMT (Moustakas and Heldin, 2007; Thiery et al., 2009) .
Among various epigenetic mechanisms of cancerrelated gene silencing, DNA hypermethylation of CpG sites within CpG-islands is known to lead to the inactivation of many tumor-suppressor genes (Herman and Baylin, 2003) and several tumor-suppressive miRNAs (miRNAs, Chuang and Jones, 2007; Kozaki et al., 2008; Furuta et al., 2009) . Epigenetic gene silencing has also been indicated to correlate with EMT processes. For example, the induction of EMT was accompanied by de novo DNA methylation of promoter regions around several genes, including E-cadherin, estrogen receptor, and TWIST, and interestingly, the repression of E-cadherin transcription preceded the subsequent acquisition of methylated CpG sites (Dumont et al., 2008) . Most recently, the TGFb-TGFbR-Smad2 signaling axis was revealed to maintain epigenetic silencing of critical EMT genes and cancer progression through modulating the DNA-binding activity of a DNA methyltransferase, DNMT1 (Papageorgis et al., 2010) . In addition, the demethylation of FOXA1/2 was described to reactivate E-cadherin expression in a pancreatic cancer cell line, Panc1 (Song et al., 2010) .
Oral cancer, predominantly oral squamous cell carcinoma (OSCC), is the most common head and neck neoplasm, affecting B270 000 people worldwide in 2002 (Parkin et al., 2005) , and leading to more than 7800 deaths annually in the United States (Greenlee et al., 2000) . In Japan, OSCC is relatively common, accounting for more than 5500 deaths in 2003 (Nomura et al., 2005) . The carcinogenesis is generally considered to arise through the progressive accumulation of multiple genetic alterations, which may impair the functions of oncogenes or tumor-suppressor genes (Scully et al., 2000) . In addition, epigenetic mechanisms, such as altered DNA methylation patterns, have a significant role in the silencing of tumor-suppressor geness and contribute to malignant transformation during oral carcinogenesis (Ha and Califano, 2006) .
We describe here the identification and characterization of EMT-related genes, WNT7A and WNT10A, silenced by mesenchymal-specific DNA hypermethylation in OSCC. Our findings suggest that mesenchymalspecific DNA hypermethylation to be required to completely stabilize the phenotypic plasticity of cancer cells during EMT.
Results

Classification of epithelial-or mesenchymal-like OSCC cell lines based on expression profiles of typical EMT-related genes
To identify novel EMT-related genes silenced by mesenchymal-specific DNA hypermethylation in a panel of OSCC cells, we first profiled the expression of 19 typical EMT-related genes in 18 OSCC cell lines and their normal counterpart RT7, an immortalized human oral keratinocyte line, and then classified the OSCC cell lines as epithelial-or mesenchymal-like (upper panel in Figure 1a ). In this analysis, the significant downregulation of six epithelial markers, five miR-200 family members and E-cadherin, and remarkable upregulation of eight mesenchymal markers, CXCL12, CXCR4, ETS1, N-cadherin, SNAI1, VIM, ZEB1 and ZEB2, were observed specifically in the HOC313 and TSU cell lines. Expression patterns of E-cadherin and Vimentin proteins in a panel of OSCC cell lines and RT7 were also validated by western blot analysis (Supplementary Figure 1) . Furthermore, based on these expression profiles, the 18 OSCC cell lines were divided into 16 epithelial-like and two mesenchymal-like cell lines. As shown in Figure 1b , a representative epitheliallike cell line, OM1, appeared as a cobblestone-shaped epithelial monolayer, whereas mesenchymal-like cell lines, HOC313 and TSU, exhibited a spindle-shaped phenotype similar to fibroblasts.
Expression-based screening of novel EMT-related genes in the Wnt signaling pathway using a panel of OSCC cell lines We next focused on the Wnt signaling pathway because some family members, such as WNT4 and WNT5A (Taki et al., 2003) , had been reported to be closely correlated with EMT in cancer. In a panel of OSCC cell lines, we examined expression profiles of 27 Wnt pathway-related genes, and found that five genes, WNT4, WNT7A, WNT7B, WNT10A, and WNT11, were downregulated specifically in the mesenchymal-like OSCC cell lines, HOC313 and TSU, although no gene was upregulated specifically in these two cell lines (lower panel in Figure 1a) .
To evaluate the possible correlation between the mesenchymal-specific downregulation of these genes and DNA hypermethylation in a mesenchymal-specific manner, we examined the restoration of expression levels of five Wnt genes and five epithelial marker genes, E-cadherin, miR-141, miR-200a, miR-200b and miR200c , with CpG-islands in the 5 0 upstream region in OSCC cell lines cultured with or without 10 mM of 5-aza 2 0 -deoxycytidine (5-aza-dCyd) for 5 days (Figure 1c) . The specific downregulation of these 10 genes in the mesenchymal-like OSCC cell lines were confirmed, whereas their expressions were detected in epitheliallike OSCC cell lines, RT7, and three non-cancerous oral mucosae. The expression of WNT7A, WNT7B, WNT10A and E-cadherin was restored specifically in mesenchymal-like OSCC cell lines after treatment with 5-aza-dCyd, but not the expression of four miR-200 family members and two Wnt genes, suggesting that mesenchymal-specific DNA hypermethylation might suppress the expression of these three Wnt genes in OSCC cell lines.
Methylation-based screening of novel EMT-related Wnt genes in OSCC cell lines To determine whether these Wnt genes were silenced by mesenchymal-specific DNA hypermethylation in OSCC cell lines, we performed the combined bisulfite restriction analysis for six CpG-islands in the 5 0 upstream region of five EMT marker genes and three candidate Wnt genes in a panel of 18 OSCC cell lines. The physical relationships between these genes, CpG-islands and the primers for combined bisulfite restriction analysis are shown in Figure 2a . DNA hypermethylation within CpG-islands around E-cadherin, miR-200b/a, WNT7A and WNT10A was detected specifically in mesenchymal-like OSCC cell lines, HOC313 and TSU, showing mesenchymal-specific downregulation of their expression, but not miR-200c/141 and WNT7B genes ( Figure 2b and Supplementary Figure 2) . Consistent with results of the combined bisulfite restriction analysis, mesenchymal-specific DNA hypermethylation was also demonstrated by bisulfite sequencing in these mesenchymal-like cell lines, but not in an epithelial-like cell line, OM1 (Supplementary Figure 3) . Therefore, we further analyzed WNT7A and WNT10A as possible candidates for EMT-related Wnt genes silenced by mesenchymal-specific DNA hypermethylation in OSCC cell lines.
Relationship between DNA hypermethylation of EMTrelated Wnt genes, WNT7A and WNT10A, and clinical characteristics in primary OSCC cases To confirm whether DNA hypermethylation within CpG-islands around WNT7A and WNT10A also occurs in primary tumors, and to further investigate the correlation between DNA methylation status and clinical characteristics in primary OSCC cases, we performed a methylation-specific PCR analysis of CpG-islands in the 5 0 upstream region of these EMT-related Wnt genes together with miR-200b/a using 17 normal oral mucosae and 50 primary OSCCs (Table 1 and Supplementary  Figure 4) . The physical relationships between these genes, CpG-islands and methylation-specific PCR primer sets are shown in Figure 2a . As hypomethylation and overexpression of miR-200b/a were previously reported in pancreatic cancer (Li et al., 2010) , the primer set described in a previous study, PS-1, was used as a control for validation of the primer set designed by us, PS-2. Primer sets for the methylation-specific PCR analysis of WNT7A and WNT10A were designated as PS-3 and PS-4, respectively. As shown in Table 2 , DNA hypermethylation of miR-200b/a was detected in almost all samples by both primer sets. On the other hand, the frequency of DNA hypermethylation in WNT7A was significantly elevated in primary tumors (78.0%, 39/50) compared with normal oral mucosae (41.2%, 7/17) (P ¼ 0.007, Fisher's exact test). In contrast, a significant difference was not found in DNA hypermethylation of WNT10A (P ¼ 0.159, Fisher's exact test), although its frequency was also increased in primary OSCCs (24.0%, 12/50) compared with normal mucosae (5.9%, 1/17). As shown in Table 3 , DNA hypermethylation of WNT7A was statistically associated with T status (P ¼ 0.040, Fisher's exact test) and stage of disease (P ¼ 0.016, 
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Region 3 Methylation analysis of six CpG-islands in the 5 0 upstream region of five EMT marker genes and three candidate Wnt genes in these cell lines was performed using combined bisulfite restriction analysis (COBRA). (a) Maps of candidate genes, CpG-islands, CpG sites and PCR products used for COBRA and bisulfite sequencing. White box, exon of candidate gene or preform sequence of candidate miRNA gene; gray box, CpG-island; closed arrows, PCR products (primers, Supplementary Table 1) ; vertical tick marks, CpG sites; vertical arrows, restriction enzyme sites. (b) Summary of DNA methylation status of CpG-islands within/around EMT-related genes and candidate genes in 18 OSCC cell lines and Panc1 cell line by COBRA. PCR products used for COBRA were digested with BstUI or TaqI, and electrophoresed (see the results of COBRA in Supplementary Figure 2) . Black, gray and white boxes indicate complete, partial and no digestion of PCR products, respectively, by restriction enzymes. MSP, methylation-specific PCR.
advanced stages of OSCC, resulting in the identification of WNT7A and WNT10A as prime candidates for genes silenced by mesenchymal-specific DNA hypermethylation in OSCC. There was no relationship between the DNA hypermethylation of these loci and gender, ethnicity, or location. We could not analyze the prognostic significance because complete survival data were not included in our clinical data.
Transcriptional regulation of WNT7A and WNT10A via the miR-200-ZEB1-E-cadherin axis To examine the transcriptional regulation of WNT7A and WNT10A, we focused on the miR-200-ZEB1-Ecadherin axis because a part of roles and significances of these pathways was elucidated using experimental models for in vitro analysis, including a pancreatic carcinoma cell line Panc1 (Burk et al., 2008 ) and a lung M  23  13  Thailander  74  Male  Tongue  2  1  0  III  M  M  U  U  24  49  Japanese  60  Male  Floor mouth  2  1  0  III  M  M  U  U  25  32  Thailander  75  Female Buccal mucosa  3  0  0  III  M  M  M  U  26  33  Thailander  90  Female Tongue  3  0  0  III  M  M  M  U  27  38  Thailander  79  Female Gingiva  3  0  0  III  M  M  M  U  28  20  Thailander  51  Male  Buccal mucosa  2  1  0  III  M  M  M  U  29  2  Thailander  82  Male  Gingiva  3  0  0  III  M  M  U  M  30  11  Thailander  75  Male  Buccal mucosa  4  1  0  IV  M  M  U  U  31  15  Thailander  40  Female Tongue  4  2  0  IV  M  U  M  U  32  27  Thailander  78  Female Buccal mucosa  4  3  0  IV  M  M  M  U  33  28  Thailander  67  Female Buccal mucosa  4  1  -IV  M  M  M  U  34  31  Thailander  55  Female Floor mouth  4  3  0  IV  M  M  M  U  35  12  Thailander  69  Male  Buccal mucosa  3  2  0  IV  M  M  M  U  36  34  Thailander  66  Male  Tongue  4  0  0  IV  M  M  M  U  37  35  Thailander  71  Female Gingiva  4  0  0  IV  M  M  M  U  38  37  Thailander  60  Male  Gingiva  4  0  0  IV  M  M  M  U  39  29  Thailander  77  Female Buccal mucosa  4  0  0  IV  M  M  M  U  40  39  Thailander  54  Female Gingiva  4  2  0  IV  M  M  M  U  41  40  Thailander  54  Female Buccal mucosa  4  1  0  IV  M  M  M  U  42  41  Japanese  74  Male  Tongue  4  0  0  IV  M  M  M  U  43  48  Japanese  60  Male  Gingiva  4  1  0  IV  M  M  M  U  44  14  Thailander  75  Male  Buccal mucosa  3  2  0  IV  M  M  M  M  45  16  Thailander  61  Female Gingiva  4  2  0  IV  M  M  M  M  46  36  Thailander  83  Female Gingiva  4  1  0  IV  M  M  M  M  47  17  Thailander  66  Male  Buccal mucosa  4  2  0  IV  M  M  M  M  48  30  Thailander  64  Male  Buccal mucosa  4  0  0  IV  M  M  M  M  49  18  Thailander  72  Female Tongue  2  2  0  IV  M  M  M  M  50  19  Thailander  74  Female Buccal Figure 5b) . Therefore, these OSCC cell lines examined by us were inadequate for an in vitro experimental model using E-cadherin expression as a biological indicator of EMT/MET, and we employed Panc1 and H661 cell lines having the phenotypic plasticity at EMT/MET for further studies. In Panc1 and H661 cell lines, almost all cells show a cobblestone appearance with epithelial features, whereas the adhesion of these cells to the culture dish and intercellular junctions tended to be looser than those of OM1 cells classified as an epithelial-like OSCC cell line (Figure 1b ). Panc1 and H661 cells expressed measurable amounts of the transcripts of E-cadherin, WNT7A and WNT10A (Figures 1c and 3a and b) although CpGislands around E-cadherin and WNT10A were partially methylated in these cell lines (Figure 2b (Figure 3a) . Consistent with these results, a marked downregulation of ZEB1 expression and significant upregulation of E-cadherin and WNT7A expressions were detected in ZEB1-knockdown Panc1 cells. In contrast, notable upregulation of WNT7A was observed in H661 cells after transfection with miR-200b, but not miR-200a (Figure 3b ). In addition, a single knockdown of either ZEB1 or ZEB2 had no effect on E-cadherin upregulation, whereas double knockdown of these targets and restoration of miR-200a or miR-200b expression markedly induced E-cadherin expression in H661 cells (Figure 3b ). The cause of differences in effects of miR-200a, ZEB1 and ZEB2 on expressions of E-cadherin and WNT7A between these cell lines remains unclear. However, these differences might arise from a balance of expression levels of ZEB1 and ZEB2 in Panc1 and H661 cells (Supplementary Figure 6) . The expression patterns of WNT10A were opposite to those of E-cadherin and WNT7A in the above-mentioned transfectants (Figures 3a and b) , thus we excluded WNT10A from our candidate genes.
Characterization of the WNT7A promoter and direct effect of ZEB1 on the promoter activity of WNT7 gene In the putative promoter 953 bp upstream from exon1 of WNT7A, we found three putative binding sequences for ZEB1, two of which were perfect E-boxes (CAGGTG or CACCTG). The third sequence was a Z-box (CAGG-TA). As shown in Figure 3c , we prepared five luciferase reporter constructs containing four different sequences (region 1-4), one of which included a mutation of the Ebox (4mut: CACCGG), and then assessed promoter activity in four regions by transiently transfecting with the five reporter constructs, the OSCC cell lines HSC-2 and NA. In the wild-type promoter, high luciferase activity was detected in regions 3 and 4 as compared with the other regions and a control construct, while promoter activity in all four regions was clearly suppressed by the overexpression of ZEB1. Moreover, ZEB1-dependent inactivation in region 4 was significantly decreased in luciferase reporter constructs containing the mutant promoter. On the other hand, we performed chromatin immunoprecipitation assay of WNT7A and E-cadherin promoters in ZEB1-expressers, Panc1 and H661, and nonexpressers, HSC-2 and NA. Promoter of E-cadherin, whose expression had been known to be directly suppressed by ZEB1 (Eger et al., 2005) , was used as a positive control for chromatin immunoprecipitation assay. Consistent with results of Mesenchymal-specific DNA hypermethylation in cancer cells Y Kurasawa et al promoter activity of WNT7 gene (Figure 3c ), it was confirmed that ZEB1 could directly bind to a highactivity region of putative WNT7A promoter in Panc1 cells (Figure 3d ). These findings suggest that the transcriptional repressor ZEB1 directly suppressed the expression of WNT7A by binding to its promoter. Although the binding of ZEB1 to WNT7A promoter was not detected in H661 cells, higher expression of ZEB2 in H661 cells might cause the difference of results between these cell lines (Supplementary Figure 6) , suggesting that WNT7A might be also downregulated by direct binding of ZEB2 to WNT7A promoter.
Effects of WNT7A on E-cadherin expression
We examined the effects of WNT7A on E-cadherin expression in Panc1 and H661 cells using a recombinant human WNT7A (rhWNT7A), specific small interfering RNA (siRNA) for WNT7A and ZEB1, and double- Positive Negative P-value Positive Negative P-value Positive Negative P-value Positive Negative P-value Total number (%) 50 (100) 0 (0) 48 (96) 2 (4) 39 (78) 11 (22) 12 (24) a and b, right panel) . These cells were analyzed 72 h after transfection. In the RT-PCR analysis (a and b, upper panel), expression levels of ZEB1, ZEB2, E-cadherin, WNT7A and WNT10A were based on the amount of target message relative to the GAPDH transcript to normalize the initial input of total RNA. Bar graphs show the ratio of the expression level in these transfectants to their control counterparts. Moreover, protein levels of ZEB1 and E-cadherin in these transfectants were analyzed by western blotting (a and b, lower panel). (c) Promoter assay of WNT7A. Top, a map of the upstream region of WNT7A, showing CpG-islands, putative ZEB1-binding sites (E-Boxes and Z-Box), and five reporter constructs. pGL3-promoter empty vectors (mock) and reporter constructs, each containing one of four different sequences in the upstream region of WNT7A (regions 1-4; primers, Supplementary Table 1), were transfected into OSCC cell lines, HSC-2 and NA, which had been confirmed to be WNT7A-expressers and ZEB1-nonexpressers. Nucleotide 'T' was mutated to 'G', indicated by italic and bold type, for further study in a reporter construct (4 mut) by the Gene Tailor Site-Directed Mutagenesis System (Invitrogen). Middle, characterization of the WNT7A promoter. Bottom, direct effect of ZEB1 on the promoter activity of WNT7 gene. Luciferase activity was analyzed 48 h after the cotransfection of each reporter construct together with either pIRES-hrGFP II-ZEB1 or the empty vector pIRES-hrGFP II-Empty, and then normalized vs an internal control. Each point represents the mean of triplicate determinations (bars, s.e.). Asterisks (*), statistical analysis with the Mann-Whitney U test. (d) Chromatin immunoprecipitation (ChIP) assay of E-cadherin and WNT7A promoter fragments in HSC-2, NA, Panc1 and H661 cells. PCR products amplified from immunoprecipitated DNA using specific primer sets designed to amplify regions (Supplementary Table 1 and Figure 3c ) were electrophoresed. Left panel, amount of E-cadherin and WNT7A in input to confirm equal loading of chromatin used for ChIP assay. Right panel, the association of ZEB1 with the proximal E-cadherin and WNT7A promoters by ChIP assay using anti-ZEB1 polyclonal antibodies or unrelated goat IgG (control).
additional knockdown of endogenous WNT7A (Figure 4b expressers than in high ZEB1-expressers. Our findings suggest that WNT7A, whose expression is negatively regulated by mesenchymal-specific DNA hypermethylation and ZEB1, may positively regulate E-cadherin expression in cancer cells (Figure 4c ).
Discussion
DNA hypermethylation of CpG-islands is considered to have crucial roles in many normal cellular processes, including proliferation, development, differentiation and apoptosis, by regulating target-gene expression through transcriptional inhibition, and to be deregulated in a wide range of human cancers (Berdasco and Esteller, 2010) . Epigenetic gene silencing has also been indicated to correlate with EMT processes (Dumont et al., 2008; Song et al., 2010) , and recent studies reported that the TGFb-TGFbR-Smad2 signaling axis maintains the epigenetic silencing of critical EMT genes, and so is relevant to cancer progression, through a modulating in the DNA-binding activity of DNA methyltransferase DNMT1 (Papageorgis et al., 2010) . In the present study, we first performed (1) the classification of epithelial-like or mesenchymal-like OSCC cell lines based on expression profiles of typical EMT-related genes and (2) the expression-based and methylation-based screening of novel EMT-related genes in the Wnt signaling pathway using a panel of classified OSCC cell lines, resulting in the identification of WNT7A and WNT10A silenced by mesenchymalspecific DNA hypermethylation in OSCC. Then, we found that the miR-200-ZEB1-WNT7A-E-cadherin pathway, as a possible subpathway of the miR-200-ZEB1-E-cadherin axis, was interrupted by DNA hypermethylation in a mesenchymal-specific manner (Figure 4c ) and that a significant relationship exists between the DNA methylation status of WNT7A and WNT10A and the clinical characteristics in primary OSCCs. Our findings indicated that the mesenchymalspecific DNA hypermethylation of CpG-islands caused the epithelial gene-specific silencing, and led us to consider that the phenotypic plasticity of mesenchymal-like cancer cells might be stabilized by mesenchymal-specific DNA hypermethylation during EMT in cancer progression.
The miR-200-ZEB1-E-cadherin axis is a crucial pathway in EMT and was described to be deregulated in mesenchymal-like cancer cells (Bracken et al., 2008; Gregory et al., 2008; Park et al., 2008) . An early study, demonstrated the promoter region of miR-200a and miR-200b was partially methylated in normal pancreas and unmethylated in pancreatic cancer (Li et al., 2010) . Our results showed that CpG-islands in the 5 0 upstream promoter region of miR-200b/a were methylated in almost all primary OSCCs and normal oral mucosae. These miRNA genes, similar to E-cadherin, WNT7A and WNT10A, were frequently methylated and remarkably downregulated in the mesenchymal-like OSCC cell lines as opposed to epithelial-like OSCC cell lines, and we successfully classified epithelial-like and mesenchymal-like OSCC cell lines based on the expression profiles of typical EMT markers, including E-cadherin, miR200a and miR-200b. The relationship between the DNA methylation status of miR-200b/a and malignancy in cancer cells and cancer progression remains unclear. The present study, moreover, clearly demonstrated the hypermethylation of CpG-islands around WNT7A and WNT10A and the loss of expression of these genes to be useful biomarkers for the classification of epithelial-like and mesenchymal-like cells, as well as predictions of malignancy in cancer cells. Actually, ectopic miR-200a and miR-200b expression could induce MET in a pancreatic carcinoma cell line Panc1 and a lung cancer cell line H661, but not in the mesenchymal-like OSCC cell lines, HOC313 and TSU. In HOC313 and TSU, the mesenchymal-specific DNA hypermethylation of E-cadherin, miR-200a and miR-200b was confirmed, whereas a restoration of gene expression by demethylation was observed in these cell lines. These findings strongly suggest that the mesenchymal-specific DNA hypermethylation of CpG-islands accompanied by epithelial gene-specific silencing stabilize the phenotypic plasticity of mesenchymal-like cells. In addition, EMT could not be completely induced in the epithelial-like OSCC cell lines including OM1 by overexpression of EMT-activator ZEB1. Therefore, as EMT phenotype of OSCC cell lines were stable, not plastic at EMT conversion, we realized that OSCC cell lines were not adequate as an in vitro experimental model using E-cadherin expression as a biological indicator of EMT/ MET, and used Panc1 and H661 cell lines for the analysis of the WNT7A pathway.
The Wnt signaling pathway is critically involved in normal and disease processes, including cancer cell invasion and metastasis (McNeill and Woodgett, 2010) . Among Wnt pathway-related genes, WNT4A and WNT5A are known to contribute to EMT (Taki et al., 2003) . WNT7A has been demonstrated to induce expression of E-cadherin through b-catenin and JNK signaling pathways in lung cancer cell lines (Ohira et al., 2003; Winn et al., 2005) . In addition, the epigenetic inactivation of WNT7A and WNT10A was described in pancreatic cancer cell lines and primary tumors and in glioblastoma and astrocytoma cell lines, respectively (Sato et al., 2003; Ordway et al., 2006) . However, no correlation of WNT7A and WNT10A with EMT and EMT-related DNA hypermethylation in cancer cells has been reported. In this study, we clearly showed WNT7A to have a part in the EMT/MET processes as a subpathway of the miR-200-ZEB1-E-cadherin axis, although the biological function of WNT10A remains unclear. Furthermore, our approach combining methylation-based and expression-based analyses in a panel of cancer cell lines classified as epithelial or mesenchymal-like, may be promising for the exploration of novel signaling pathways and therapeutic targets in cancer cells. As very little is known about WNT7A and WNT10A, our studies may motivate further research into their biological and functional significance.
In conclusion, WNT7A was silenced by mesenchymalspecific DNA hypermethylation or ZEB1 in at least two mesenchymal-like OSCC cell lines, HOC313 and TSU, and might contribute to MET, in a mesenchymal-like pancreatic cancer cell line Panc1. Furthermore, our results show that the DNA hypermethylation of CpGislands around exon 1 of WNT7A and WNT10A is cancer specific at the advanced stages of OSCC. Another important finding was that epithelial-specific gene silencing of E-cadherin, WNT7A and WNT10A, for example, through mesenchymal-specific DNA hypermethylation stabilized the phenotypic plasticity of cancer cells in a multistep process with the acquisition of genetic and epigenetic aberrations.
Materials and methods
Cell lines and primary tumor samples
Derivations of and culture conditions for cell lines have been reported previously (Suzuki et al., 2007) . OSCC cell lines were authenticated in our previous studies of array-based comparative genomic hybridization (array-CGH) analyses (Suzuki et al., 2007) . To analyze the restoration of genes of interest, cells were cultured with or without 10 mM of 5-aza-dCyd for 5 days. Primary OSCCs and normal oral mucosae from Japanese and Thai nationals were obtained after approval by a local ethics committee in each country. The TNM (tumor-nodemetastasis) classification of Union for International Cancer Control was used. Recombinant human WNT7A was purchased from R&D systems (Minneapolis, MN, USA).
Methylation analysis
Genomic DNA was treated with sodium bisulfite and subjected to PCR using primer sets designed to amplify regions of interest (Supplementary Table 1) . Genomic DNA extraction, combined bisulfite restriction analysis and the bisulfite-sequencing analysis were performed as described elsewhere .
TaqMan real-time reverse transcription-PCR RNA extraction and real-time reverse transcription-PCR were performed as described elsewhere . Relative expression levels of protein-coding genes and miRNAs were quantified in comparison to GAPDH mRNA and RNU6B, respectively.
Statistical analysis
The association between DNA hypermethylation and clinicopathological characteristics was evaluated with Fisher's exact test and the w 2 -test. A P-value o0.05 was defined as being statistically significant. Differences between subgroups were tested with the Mann-Whitney U test.
Transfection with synthetic miRNAs, small interfering RNAs and the ZEB1 expression vector Double-stranded RNA (dsRNA) mimicking human mature miRNA of 10 nM or control nonspecific miRNA (Ambion, Austin, TX, USA), and 20 nM of siRNA for ZEB1 or control nonspecific siRNA (Dharmacon Products, Thermo Fisher Scientific, Lafayette, CO, USA) were transfected individually into OSCC cells using Lipofectamine RNAiMAX (Invitrogen, Carlsbad, CA, USA) according to the manufacturer's instructions. A ZEB1 expression vector (pIRES-hrGFP II-ZEB1), luciferase reporter constructs and pRL-hTK were transfected using Lipofectamine 2000 (Invitrogen) or FuGENE (Roche, Basel, Switzerland).
